Skip to main content
logo
Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.66
+0.20 (3.10%)
Aug 18, 2026, 12:21 PM EDT - Market open

Journey Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
68.1861.8656.1379.1873.6763.13
Revenue Growth
20.89%10.20%-29.11%7.48%16.69%41.77%
Gross Profit
44.6340.9335.2656.2942.8937.55
Operating Income
-3.01-8.17-13.681.07-27.52-18.84
Net Income
-6.1-11.43-14.67-3.85-29.63-43.99
Earnings Per Share
-0.23-0.47-0.72-0.21-1.69-4.32
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
25.6424.0920.3127.443249.08
Total Debt
25.5425.425.7117.7326.629.05
Net Cash (Debt)
0.1-1.31-5.49.715.3840.03
Net Cash Growth
---80.40%-86.56%-
Net Cash Per Share
0.00-0.05-0.260.530.313.93

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.49-12.44-9.135.24-13.53-2.18
Capital Expenditures
------
Free Cash Flow
-7.49-12.44-9.135.24-13.53-2.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
65.45%66.17%62.80%71.09%58.23%59.48%
Operating Margin
-4.41%-13.21%-24.37%1.35%-37.35%-29.84%
Pretax Margin
-8.93%-18.38%-26.03%-4.59%-40.13%-67.10%
Profit Margin
-8.95%-18.48%-26.14%-4.87%-40.22%-69.68%
FCF Margin
-10.99%-20.11%-16.26%6.62%-18.37%-3.45%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
32.7161.68----
P/FCF Ratio
---20.35--
PS Ratio
2.723.381.461.350.461.42